Herbas VPB

Print
EN | LT
LT - UNIT DOSE FORMULATION OF ANTIDOTE FOR FACTOR XA INHIBITORS FOR USE IN PREVENTING BLEEDING
EN - UNIT DOSE FORMULATION OF ANTIDOTE FOR FACTOR XA INHIBITORS FOR USE IN PREVENTING BLEEDING

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 38/48
C12N 9/64
A61P 7/00
A61P 7/04
European patent
(11) Number of the document 2453910
(13) Kind of document T
(96) European patent application number 10737699.8
Date of filing the European patent application 2010-07-14
(97) Date of publication of the European application 2012-05-23
(45) Date of publication and mention of the grant of the patent 2016-08-31
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2010/042015
Date 2010-07-14
PCT application publication
(87) Number WO 2011/008885
Date 2011-01-20
Priority applications
(30) Number Date Country code
225887 P 2009-07-15 US
Inventors
(72)
SINHA, Uma, US
LU, Genmin, US
HUTCHALEELAHA, Athiwat, US
HOLLENBACH, Stanley J., US
Grantee
(73) Portola Pharmaceuticals, Inc., 270 East Grand Avenue Suite 22, South San Francisco California 94080, US
Title
(54) UNIT DOSE FORMULATION OF ANTIDOTE FOR FACTOR XA INHIBITORS FOR USE IN PREVENTING BLEEDING
  UNIT DOSE FORMULATION OF ANTIDOTE FOR FACTOR XA INHIBITORS FOR USE IN PREVENTING BLEEDING
Last update date 2021-04-30